MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

Search

Avita Therapeutics Inc

Fechado

3.87 0.26

Visão Geral

Variação de preço das ações

24h

Atual

Mín

3.7800000000000002

Máximo

3.94

Indicadores-chave

By Trading Economics

Rendimento

1.6M

-12M

Vendas

554K

18M

Margem de lucro

-65.968

Funcionários

226

EBITDA

1.6M

-9.7M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+62.31% upside

Dividendos

By Dow Jones

Próximos Ganhos

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-4M

119M

Abertura anterior

3.61

Fecho anterior

3.87

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Avita Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

7 de abr. de 2026, 17:26 UTC

Notícias Principais

EIA Raises Oil-Price Forecasts as War in Middle East Continues

7 de abr. de 2026, 23:55 UTC

Conversa de Mercado

Genesis Energy Signals Higher Dividend Payout Ratios -- Market Talk

7 de abr. de 2026, 23:47 UTC

Conversa de Mercado
Notícias Principais

Market Talk Roundup: Latest on U.S. Politics

7 de abr. de 2026, 23:47 UTC

Conversa de Mercado
Notícias Principais

Precious Metals Rise, Boosted by Dollar Weakness, Lower Treasury Yields -- Market Talk

7 de abr. de 2026, 23:44 UTC

Conversa de Mercado
Notícias Principais

Gold Rallies as Trump Remarks Send Oil Prices Lower -- Market Talk

7 de abr. de 2026, 23:42 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

7 de abr. de 2026, 23:42 UTC

Conversa de Mercado

Nikkei Likely to Rise After Trump Agrees to Cease-Fire With Iran -- Market Talk

7 de abr. de 2026, 23:37 UTC

Conversa de Mercado
Notícias Principais

Oil Futures Fall After Trump Agrees to Two-Week Cease-Fire With Iran -- Market Talk

7 de abr. de 2026, 23:15 UTC

Conversa de Mercado
Notícias Principais

Markets Will Want Fast Evidence That Ships Are Moving -- Market Talk

7 de abr. de 2026, 23:04 UTC

Notícias Principais

Spot Gold Rises 2.5%, Spot Silver Climbs 4.9%

7 de abr. de 2026, 23:04 UTC

Notícias Principais

Precious Metals Rise After Trump Agrees to Ceasefire With Iran

7 de abr. de 2026, 23:03 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 de abr. de 2026, 23:03 UTC

Conversa de Mercado

Middle East Ceasefire Triggers Australian Dollar Rally -- Market Talk

7 de abr. de 2026, 23:01 UTC

Notícias Principais

Front-Month WTI Crude Oil Futures Falls 13.7% to $97.47 per Barrel

7 de abr. de 2026, 22:58 UTC

Notícias Principais

Front-Month Crude Oil Futures Slide After Trump Agrees to Cease-Fire With Iran

7 de abr. de 2026, 21:56 UTC

Aquisições, Fusões, Aquisições de Empresas

Telefónica Sells All Shares in Pegaso PCS, Celular de Telefonía

7 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Basic Materials Roundup: Market Talk

7 de abr. de 2026, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

7 de abr. de 2026, 19:45 UTC

Conversa de Mercado

Treasury Yields Mixed as Investors Brace for Iran Deadline -- Market Talk

7 de abr. de 2026, 19:17 UTC

Notícias Principais

The Risks to the Gulf Region's Oil Are Immense. Are Markets Shrugging Them Off? -- Barrons.com

7 de abr. de 2026, 19:16 UTC

Conversa de Mercado

Cold Shot Helps U.S. Natural Gas Futures Settle Higher -- Market Talk

7 de abr. de 2026, 19:07 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

7 de abr. de 2026, 19:07 UTC

Conversa de Mercado

Oil Futures Mixed Ahead of Trump's Iran Deadline -- Market Talk

7 de abr. de 2026, 18:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Eldorado Gold: Total of 149.6M Common Shrs, Representing 75.31% of Votes Attached to All Outstanding Common Shrs, Were Voted >ELD.T

7 de abr. de 2026, 18:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Eldorado Gold Holders Voted to Approve Issuance of Common Shrs in Connection With Proposed Plan of Arrangement With Foran Mining >ELD.T

7 de abr. de 2026, 18:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Eldorado Gold Reports Voting Results From Special Meeting of Hldrs

7 de abr. de 2026, 18:24 UTC

Notícias Principais

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7 de abr. de 2026, 17:08 UTC

Conversa de Mercado

Latin America Less Exposed to Crude Supply Disruptions -- Market Talk

7 de abr. de 2026, 16:21 UTC

Notícias Principais

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7 de abr. de 2026, 16:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

Comparação entre Pares

Variação de preço

Avita Therapeutics Inc Previsão

Preço-alvo

By TipRanks

62.31% parte superior

Previsão para 12 meses

Média 6.33 USD  62.31%

Máximo 10 USD

Mínimo 3.5 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Avita Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

4 ratings

2

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

8.83 / 9.77Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

Weak Bearish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
help-icon Live chat